NVAX NOVAVAX INC

Nasdaq novavax.com


$ 7.12 $ -0.45 (-5.95 %)    

Monday, 10-Nov-2025 15:25:13 EST
QQQ $ 623.31 $ 4.52 (0.73 %)
DIA $ 473.74 $ 1.88 (0.4 %)
SPY $ 681.65 $ 4.47 (0.66 %)
TLT $ 89.46 $ -0.03 (-0.03 %)
GLD $ 378.36 $ 2.42 (0.64 %)
$ 7.44
$ 7.57
$ 7.11 x 901
$ 7.12 x 700
$ 7.08 - $ 7.59
$ 5.01 - $ 11.55
5,056,721
na
1.21B
$ 1.77
$ 3.54
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-06-2025 09-30-2025 10-Q
2 08-06-2025 06-30-2025 10-Q
3 05-08-2025 03-31-2025 10-Q
4 02-27-2025 01-01-1970 10-K
5 11-12-2024 09-30-2024 10-Q
6 08-08-2024 06-30-2024 10-Q
7 05-10-2024 03-31-2024 10-Q
8 02-28-2024 12-31-2023 10-K
9 11-09-2023 09-30-2023 10-Q
10 08-08-2023 06-30-2023 10-Q
11 05-09-2023 03-31-2023 10-Q
12 02-28-2023 12-31-2022 10-K
13 11-09-2022 09-30-2022 10-Q
14 08-08-2022 06-30-2022 10-Q
15 05-09-2022 03-31-2022 10-Q
16 03-01-2022 12-31-2021 10-K
17 11-04-2021 09-30-2021 10-Q
18 08-05-2021 06-30-2021 10-Q
19 05-10-2021 03-31-2021 10-Q
20 03-01-2021 12-31-2020 10-K
21 11-10-2020 09-30-2020 10-Q
22 08-10-2020 06-30-2020 10-Q
23 05-11-2020 03-31-2020 10-Q
24 03-11-2020 12-31-2019 10-K
25 11-07-2019 09-30-2019 10-Q
26 08-07-2019 06-30-2019 10-Q
27 05-02-2019 03-31-2019 10-Q
28 03-18-2019 12-31-2018 10-K
29 11-07-2018 09-30-2018 10-Q
30 08-08-2018 06-30-2018 10-Q
31 05-09-2018 03-31-2018 10-Q
32 03-14-2018 12-31-2017 10-K
33 11-07-2017 09-30-2017 10-Q
34 08-08-2017 06-30-2017 10-Q
35 05-08-2017 03-31-2017 10-Q
36 02-27-2017 12-31-2016 10-K
37 11-09-2016 09-30-2016 10-Q
38 08-09-2016 06-30-2016 10-Q
39 05-05-2016 03-31-2016 10-Q
40 02-29-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 b-riley-securities-reiterates-buy-on-novavax-lowers-price-target-to-16

B. Riley Securities analyst Mayank Mamtani reiterates Novavax (NASDAQ:NVAX) with a Buy and lowers the price target from $18 ...

 ai-stocks-slide-again-bitcoin-dips-near-100000-whats-moving-markets-thursday

After a brief and cautious rebound on Wednesday, risk-off sentiment returned sharply on Thursday, with AI-linked stocks leading...

 update-novavax-q3-adj-eps-048-beats-119-estimate-sales-70445m-beat-42133m-estimate

Novavax (NASDAQ:NVAX) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(1.19) by 59...

 novavax-raises-fy2025-sales-guidance-from-1000b-1050b-to-1040b-1060b-vs-1051b-est

Novavax (NASDAQ:NVAX) raises FY2025 sales outlook from $1.000 billion-$1.050 billion to $1.040 billion-$1.060 billion vs $1.051...

 novavax-q3-eps-125-beats-133-estimate-sales-70445m-beat-42133m-estimate

Novavax (NASDAQ:NVAX) reported quarterly losses of $(1.25) per share which beat the analyst consensus estimate of $(1.33) by 6....

 an-overview-of-novavaxs-earnings
An Overview of Novavax's Earnings
11/05/2025 19:03:19

 td-cowen-maintains-hold-on-novavax-lowers-price-target-to-7

TD Cowen analyst Brendan Smith maintains Novavax (NASDAQ:NVAX) with a Hold and lowers the price target from $8 to $7.

 top-stocks-with-earnings-this-week-joby-ionq-amd-and-more

Retail investors are preparing for another busy week of earnings season with more than 1,600 companies set to report through Fr...

Core News & Articles

https://www.bloomberg.com/news/articles/2025-10-28/us-fires-top-health-official-who-opposed-widely-used-covid-shots?srnd=homepa...

 cantor-fitzgerald-initiates-coverage-on-novavax-with-overweight-rating-announces-price-target-of-18

Cantor Fitzgerald analyst Pete Stavropoulos initiates coverage on Novavax (NASDAQ:NVAX) with a Overweight rating and announc...

 hc-wainwright--co-maintains-buy-on-novavax-raises-price-target-to-11

HC Wainwright & Co. analyst Sean Lee maintains Novavax (NASDAQ:NVAX) with a Buy and raises the price target from $10 to ...

 hedge-fund-shah-capital-urges-novavax-to-consider-sale-amid-vaccine-rollout-struggles-sees-5-billion-potential

Shah Capital urges Novavax to consider a sale after poor COVID-19 vaccine rollout, highlighting the potential value of at least...

 shah-capital-urges-novavax-board-to-pursue-strategic-review-and-potential-sale-amid-persistent-underperformance-and-market-share-losses

- SEC 13D/ Amended Filing

 novavax-completes-eu-marketing-authorization-transfer-of-covid-19-vaccine-to-sanofi-secures-25m-milestone-payment

Reports $220 Million in Aircraft SalesNovavax, Inc. (NASDAQ:NVAX) has completed the transfer of the marketing authorization for...

Core News & Articles

GAITHERSBURG, Md., Sept. 30, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced progress on its collaboration an...

 robert-f-kennedy-jr-faces-impeachment-push-from-haley-stevens-over-health-care-chaos-and-rising-costs-enough-is-enough

Rep. Haley Stevens (D-Mich.) announced that she will introduce articles of impeachment against Health and Human Services Secret...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION